NRx Pharmaceuticals (NRXP) AGM 2026 summary

Opening remarks and agenda

• Meeting opened with logistical instructions for participation and Q&A procedures.

• Chairman called the meeting to order, thanked participants, and expressed intent for future in-person meetings.

• Order of business and rules of conduct were presented to attendees.

Board and executive committee updates

• Proposal to elect Chaim Hurvitz and Michael Taylor as Class one directors for a three-year term was introduced.

Shareholder proposals

• Proposal to amend the 2021 Omnibus Incentive Plan was presented.

• Proposal to ratify Weinberg & Company as independent auditors for 2025 was discussed, with rationale for auditor change explained.

• Proposal for a non-binding advisory vote on executive compensation was introduced.